|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.66 USD | -4.08% |
|
+3.01% | +11.42% |
| 06-29 | Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing | MT |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | -9.25x | 4.31x | 4.14x | -7.65x | -7.18x | 2.3B | ||
| 0.59% | 0.67% | 17.35x | 1.99x | 3.77x | 10.12x | 11.2x | 67.61B | ||
| 0.62% | 0.63% | 25.62x | 3.84x | 5.26x | 15.43x | 19.24x | 51.6B | ||
| -.--% | -.--% | 34.5x | 6.94x | 11.72x | 22.4x | 26.1x | 43B | ||
| 3.34% | 3.42% | -46.01x | 2.51x | 3.23x | 9.56x | 11.15x | 40.94B | ||
| -.--% | -.--% | 30.35x | 1.57x | 3.47x | 10.97x | 12.85x | 29.4B | ||
| -.--% | -.--% | -7.88x | 4.78x | 11.31x | -6.94x | -6.56x | 27.09B | ||
| -.--% | -.--% | 37.89x | 3.39x | 3.25x | 9.81x | 11.83x | 23.32B | ||
| -.--% | 0.05% | 62.11x | 5.74x | 6.31x | 43.4x | 42.53x | 19.92B | ||
| -.--% | -.--% | 26.16x | 3.67x | 5.4x | 14.45x | 19.92x | 16.91B | ||
| -.--% | -.--% | -39.11x | -6.85x | 18.26x | -55.41x | -57.94x | 16.84B | ||
| -.--% | -.--% | -114.23x | 12383.47x | 12.15x | -87.18x | -121.4x | 12.03B | ||
| 0.16% | 0.16% | 59.28x | 24.17x | 35.96x | 50.86x | 52.45x | 11.56B | ||
| -.--% | -.--% | 16.79x | - | 3.58x | 13.11x | 15.71x | 11.43B | ||
| -.--% | -.--% | 47.49x | - | - | - | - | 10.78B | ||
| 2.87% | 3.31% | 11.71x | 1.02x | 1.8x | 7.25x | 9.72x | 6.16B | ||
| 0.36% | 0.42% | 28.61x | - | 7.69x | 20.41x | 24.37x | 5.83B | ||
| 1.57% | 1.74% | 14.36x | 1.32x | 2.54x | 6.57x | 7.96x | 5.76B | ||
| Average | 0.53% | 0.58% | 10.87x | 829.46x | 8.22x | 4.54x | 4.23x | 22.36B | |
| Weighted average by Cap. | 0.59% | 0.63% | 12.41x | 401.52x | 7.28x | 8.29x | 9.11x |
- Stock Market
- Stocks
- ZLAB Stock
- Sector Zai Lab Limited
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















